N-acetylcysteine attenuates oxidative stress and liver pathology in rats with non-alcoholic steatohepatitis

World Journal of Gastroenterology

Volumn 13, Issue 38, 2007, Pages 5127-5132

  Thong Ngam, Duangporn ^a   Samuhasaneeto, Suchittra ^a   Kulaputana, Onanong ^a   Klaikeaw, Naruemon ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

N acetylcysteine; Non alcoholic steatohepatitis; Oxidative stress

Indexed keywords

ACETYLCYSTEINE; GLUTATHIONE; MALONALDEHYDE;

ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG TISSUE LEVEL; HISTOPATHOLOGY; LIPID DIET; LIPID STORAGE; LIVER DISEASE; LIVER NECROSIS; MALE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; RANDOMIZATION; RAT; SPRAGUE DAWLEY RAT;

EID: 34948823454     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v13.i38.5127     Document Type: Article

References (35)

1. Chalasani N, Deeg MA, Crabb DW. Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis. Am J Gastroenterol 2004; 99: 1497-1502
2. Te Sligte K, Bourass I, Sels JP, Driessen A, Stockbrugger RW, Koek GH. Non-alcoholic steatohepatitis: review of a growing medical problem. Eur J Intern Med 2004; 15: 10-21
3. DeFronzo RA. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia and atherosclerosis. Neth J Med 1997; 50: 191-197
4. Medina J, Fernandez-Salazar LI, Garcia-Buey L, Moreno-Otero R. Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis. Diabetes Care 2004; 27: 2057-2066
5. Campfield LA, Smith FJ, Burn P. The OB protein (leptin) pathway--a link between adipose tissue mass and central neural networks. Horm Metab Res 1996; 28: 619-632
6. Weltman MD, Farrell GC, Liddle C. Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation. Gastroenterology 1996; 111: 1645-1653
7. Koteish A, Diehl AM. Animal models of steatosis. Semin Liver Dis 2001; 21: 89-104
8. Lieber CS, Leo MA, Mak KM, Xu Y, Cao Q, Ren C, Ponomarenko A, DeCarli LM. Model of nonalcoholic steatohepatitis. Am J Clin Nutr 2004; 79: 502-509
9. Garcia-Ruiz C, Colell A, Morales A, Kaplowitz N, Fernandez-Checa JC. Role of oxidative stress generated from the mitochondrial electron transport chain and mitochondrial glutathione status in loss of mitochondrial function and activation of transcription factor nuclear factor-kappa B: studies with isolated mitochondria and rat hepatocytes. Mol Pharmacol 1995; 48: 825-834
10. Weltman MD, Farrell GC, Liddle C. Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation. Gastroenterology 1996; 111: 1645-1653
11. Robino G, Parola M, Marra F, Caligiuri A, De Franco RM, Zamara E, Bellorno G, Gentilini P, Pinzani M, Dianzani MU. Interaction between 4-hydroxy-2,3-alkenals and the platelet-derived growth factor-beta receptor. Reduced tyrosine phosphorylation and downstream signaling in hepatic stellate cells. J Biol Chem 2000; 275: 40561-40567
12. Gulbahar O, Karasu A, Ersoz G, Akarca US, Musoglu A. Treatment of non-alcoholic steatohepatitis with N- acetyl cysteine. Gastroenterology 2000; 118: A1444
13. Pastor A, Collado PS, Almar M, Gonzalez-Gallego J. Antioxidant enzyme status in biliary obstructed rats: effects of N-acetylcysteine. J Hepatol 1997; 27: 363-370
14. Gulbahar O, Karasu A, Ersoz G, Akarca US, Musoglu A. N-acetyl cysteine in the treatment of non-alcoholic steatohepatitis. J Gastroenterology 2003; 18: 1220-1221
15. Samuhasaneeto S, Thong-Ngan D, Kulaputana O, Pathumraj S, Klaikeaw N. Effects of N-acetylcysteine on oxidative stress in rats with nonalcoholic steatohepatitis. J Med Assoc Thai 2007; 90: 788-797
16. Thong-Ngam D, Samuhasaneeto S, Suyasunanont D, Wisedopas N. Development of a simple rat model of nonalcoholic steatohepatitis. Thai J Gastroenterol 2005; 6: 144-148
17. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351-358
18. Lowry oh, rosebrough nj, farr al, randall rj. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-275
19. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999; 94: 2467-2474
20. Brody T. Nutritional biochemistry. 2nd ed. The United States: Academic Press, 1994: 243-245
21. Benzie IF. Lipid peroxidation: a review of causes, consequences, measurement and dietary influences. Int J Food Sci Nutr 1996; 47: 233-261
22. de Knegt RJ. Non-alcoholic steatohepatitis: clinical significance and pathogenesis. Scand J Gastroenterol Suppl 2001; 234: 88-92
23. Day CP. Pathogenesis of steatohepatitis. Best Pract Res Clin Gastroenterol 2002; 16: 663-678
24. Kaplowitz N. Liver and biliary diseases. Baltimore: Williams & Wilkins, 1992: 383
25. Robbins SL. Pathologic basic of disease. London: W. B. Soder Company, 1974: 25-30
26. Fan JG, Zhong L, Xu ZJ, Tia LY, Ding XD, Li MS, Wang GL. Effects of low-calorie diet on steatohepatitis in rats with obesity and hyperlipidemia. World J Gastroenterol 2003; 9: 2045-2049
27. Leclercq IA, Farrell GC, Field J, Bell DR, Gonzalez FJ, Robertson GR. CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis. J Clin Invest 2000; 105: 1067-1075
28. Kirsch R, Clarkson V, Shephard EG, Marais DA, Jaffer MA, Woodburne VE, Kirsch RE, Hall Pde L. Rodent nutritional model of non-alcoholic steatohepatitis: species, strain and sex difference studies. J Gastroenterol Hepatol 2003; 18: 1272-1282
29. George J, Pera N, Phung N, Leclercq I, Yun Hou J, Farrell G. Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis. J Hepatol 2003; 39: 756-764
30. Guyton AC, Hall JE. Textbook of Medical physiology. 10th ed. The United States W. B. Saunders, 2000: 788
31. Meister A, Larsson A. Glutathione synthetase deficiency and other disorders of the γ-glutamyl cycle. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic basis of inherited disease. New York McGraw-Hill, 1989; 855-868
32. Hayes JD, McLellan LI. Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress. Free Radic Res 1999; 31: 273-300
33. Koruk M, Taysi S, Savas MC, Yilmaz O, Akcay F, Karakok M. Oxidative stress and enzymatic antioxidant status in patients with nonalcoholic steatohepatitis. Ann Clin Lab Sci 2004; 34: 57-62
34. Cotgreave IA. N-acetylcysteine: pharmacological considerations and experimental and clinical applications. Adv Pharmacol 1997; 38: 205-227
35. Guthrie HA. Introductory nutrition. 6th ed. St Louis: Times Mirror/Mosby College Publishing, 1986: 11